Strepsils Max

Quick links to important sections

Strepsils Max

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Strepsils Max

Property Description
Active ingredient Hexylresorcinol
Form Oral Lozenge
Pharmacological class Local Anaesthetic, Topical Antiseptic
Common use Temporary relief of sore throat and mouth irritation
Origin Synthetic organic compound

What Type of Medicine is Strepsils Max? (Definition and Classification)

Strepsils Max is an established Over-The-Counter (OTC) medicine, primarily intended as a topical oropharyngeal preparation for direct use on the throat and mouth. Its pharmacological identity is defined by a distinct dual action, functioning simultaneously as both a potent local anaesthetic and a topical antiseptic. The designation 'Max' in the brand positioning historically signifies an enhanced level of active ingredient or symptomatic relief compared to standard Strepsils formulations. This dual function is clinically recognized for contributing to effective, prompt symptomatic relief when a patient is experiencing acute pain and irritation, distinguishing it from products that rely solely on surface-level soothing or simple antiseptic action.

Hexylresorcinol: Composition and Core Active Ingredient

The medicine is supplied as an oral lozenge, a solid dosage form engineered to dissolve slowly, facilitating the local administration of its single active component, Hexylresorcinol. This ingredient is a synthetic organic compound, chemically defined as a substituted dihydroxybenzene and a phenol derivative. Hexylresorcinol exhibits rapid release into the saliva, supporting its ability to quickly initiate both the anaesthetic and antimicrobial effects at the local site of irritation. The lozenge format itself, composed of the active substance within a solid sugar matrix, is a unique element designed for passive, sustained delivery, ensuring a prolonged demulcent effect that continuously lubricates and soothes the irritated throat membranes.

Regulatory References

  1. DrugBank

What side effects are possible with Strepsils Max?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and key safety considerations for this medicine, strictly based on regulatory documentation.

Adverse Reactions Scope

The most frequently reported adverse reactions are classified under Gastrointestinal Disorders and Immune System Disorders. These officially documented reactions include discomfort in the mouth, nausea, abdominal pain, and, less commonly, glossodynia (painful tongue) and dyspepsia (indigestion).

Serious adverse reactions primarily relate to severe Hypersensitivity Reactions (allergic reactions), which can manifest as conditions like angioedema (swelling beneath the skin) and anaphylaxis.

Classification Examples of Reactions
Immune System Disorders Hypersensitivity, Angioedema
Gastrointestinal Disorders Abdominal pain, Nausea, Mouth discomfort

Frequency and Safety Limitations

The frequency of all listed adverse reactions is officially classified as Not known (cannot be estimated from the available data).

Safety Restrictions: The medicine is formally Contraindicated (should not be used) in individuals with a known hypersensitivity to the active ingredients (Flurbiprofen or Cetylpyridinium Chloride) or to any of the specific excipients (inactive ingredients) found in the lozenge. Individuals with known allergies or intolerances to components, such as specific sugars, must avoid use.

Population-Specific Safety: Caution is advised for use during pregnancy and breast-feeding due to limited or no data on the active substances in these specific populations. Use should only occur after careful assessment by a healthcare professional.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory overdose profile for Hexylresorcinol, the active ingredient in Strepsils Max, is defined by its topical application and low systemic absorption characteristics. Official documentation from regulatory bodies states that the primary clinical manifestation of an overdose, following excessive oral ingestion of the lozenge, is generally limited to minor gastrointestinal irritation. This presentation is consistent with the medicine’s recognized action being localized primarily to the oro-pharyngeal cavity. Due to this localized profile, the official labeling typically does not document severe or life-threatening systemic outcomes, such as major cardiovascular or neurological events, in the context of overdose, and no specific antidote is known or listed in the product information.

Despite the typically minor clinical presentation, regulatory authorities strictly mandate immediate action in all instances of suspected overdose. The official instruction requires individuals to seek immediate medical attention or to contact a Poison Control Center immediately for appropriate clinical guidance. Management, as described in prescribing information, is focused on symptomatic measures as needed and the immediate discontinuation of the product. Regulatory documents do not specify unique population-specific monitoring requirements or enhanced risk considerations for groups such as pediatric or elderly patients.

Therapeutic Uses of Strepsils Max

What Strepsils Max Treats: Main Uses and Benefits

This product is commonly used to provide temporary symptomatic relief across therapeutic domains involving acute or disruptive symptom patterns, primarily targeting the sore throat and associated discomfort. The lozenge is applied in situations involving certain distressing symptoms, including acute pain, burning sensations, and general oropharyngeal irritation. Provides support that helps ease symptoms related to physical discomfort. This support assists with maintaining functional stability during symptomatic phases and contributes to comfort when symptoms interfere with routine activities.

It is relevant across domains where additional symptomatic support is needed, particularly for symptoms related to inflammatory or irritative states like scratchiness or general oropharyngeal discomfort. It is used for managing symptom clusters that may become intense or disruptive, contributing to comfort during periods of heightened symptoms. Furthermore, it is relevant in contexts involving symptoms linked to organ-specific functional stress.

Quick Fact: Relevant for Acute Sore Throat Pain

Eligibility and Restrictions for Use

Who can and cannot use Strepsils Max?

The population eligibility for Strepsils Max (Hexylresorcinol lozenges) is defined by official regulatory documentation, establishing clear rules for approved use, absolute contraindications, and conditional restrictions.


Contraindicated Populations (Use Prohibited)

Use of this medicine is absolutely contraindicated (must not be used) for the following groups:

  • Children under 6 years of age. Use is prohibited due to unestablished safety and efficacy, and potential physical hazards associated with the lozenge format.
  • Individuals with a known hypersensitivity or allergy to the active ingredient, hexylresorcinol, or to any of the lozenge's excipients.
  • Patients diagnosed with rare hereditary sugar intolerances, specifically fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency.

Approved Ages and Conditional Use

  • Approved Age: Use is formally permitted for adults and children aged 6 years and over. No dosage modification is typically necessary for the elderly population.
  • Pregnancy and Lactation: Use during both pregnancy and breastfeeding is advised with caution. This status reflects regulatory acknowledgment of limited or unavailable clinical data on the effects and safety in these specific patient populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction profile of Strepsils Max (Hexylresorcinol 2.4mg) as reported in government regulatory documents.

Interaction Scope

The regulatory profile for Hexylresorcinol lozenges is characterized by the explicit finding of minimal systemic absorption. Due to the active substance primarily providing a localized therapeutic effect within the mouth and throat, its potential for systemic interactions with other medicines is considered negligible.

Category Regulatory Status
Documented Systemic Interactions None known or explicitly listed.
Contraindicated Combinations None formally documented in regulatory labels.
Metabolic (CYP) or Transporter Interactions None documented.
Administration Timing Restrictions None required or specified.
Interactions with Food, Alcohol, or Herbal Products None documented.

Official Interaction Statement

Official government regulatory documents consistently state that no clinically significant interactions with other medicinal products are known for Hexylresorcinol lozenges. This determination is based on the compound's localized action and the absence of systemic exposure that would otherwise be required to mediate drug-drug interactions, such as those involving enzyme systems or transporters. Consequently, the regulatory documentation does not specify mandatory co-administration prohibitions or special timing requirements for this product.

Mechanism of Action

The mechanism of action of Strepsils Max is rooted in the dual pharmacological activity of its single component, Hexylresorcinol, which is strictly localized to the oropharyngeal area. The molecule engages two primary mechanistic domains that lead to its observed physiological consequences.

Modulation of Peripheral Sensory Nerve Conduction

This domain addresses the rapid suppression of sensory perception by targeting Voltage-Gated Neuronal Sodium Channels (Nav) in the throat's peripheral sensory nerves. Hexylresorcinol functions as a reversible inhibitor that blocks the Na^+ ion influx necessary for initiating a nerve impulse, thereby suppressing the entire nociceptive signaling pathway. This molecular event results in the physiological consequence of localized suppression of sensory nerve conduction in the area of application.

Disruption of Microbial Cell Membrane Integrity

The second domain provides an antimicrobial mechanism by acting on the phospholipid bilayers that form the cell membranes of susceptible bacteria and fungi. The molecule embeds itself into these membranes, disrupting their structural integrity and permeability. This leads to the fundamental physiological consequence of microbial cell lysis and death (bactericidal and fungicidal action), which reduces the localized concentration of viable pathogens.

Dosage and Administration Information

Official Administration Guidelines

Strepsils Max, a 2.4 mg Hexylresorcinol lozenge, is administered strictly via the oral route for local action on the mouth and throat. The instructions for use are defined by regulatory documents to establish a structured, short-term usage protocol.


Dosing and Frequency

The standard single unit dose is one lozenge containing 2.4 mg of Hexylresorcinol. Dosing is scheduled on an as-needed/intermittent basis, with administration repeated at intervals of every three hours. The maximum authorized daily intake is strictly limited, with a total of no more than 12 lozenges in any 24-hour period.


Administration Technique and Duration

The essential administration instruction is that the lozenge must be dissolved slowly in the mouth to facilitate local release; it must not be chewed or swallowed whole. Use is specifically constrained to short-term duration, with the course of administration generally limited to a maximum of three consecutive days.


Population-Specific Rules

The approved dosing regimen is the same for adults, the elderly, and children aged 6 years and over. The product is not authorized for administration in children under six years old. No special dose adjustments are documented in the regulatory information for the elderly population.

Recent Clinical Evidence

Strepsils Max: Recent Clinical Evidence

Clinical research has focused on evaluating the symptomatic relief provided by lozenges containing the active ingredients Amylmetacresol (AMC) and 2,4-Dichlorobenzyl Alcohol (DCBA).

Core Efficacy Studies

Studies, including randomized, controlled trials (RCTs), have been conducted to assess the effects of the AMC/DCBA combination compared to unmedicated lozenges (placebo) in individuals experiencing acute sore throat due to upper respiratory tract infections.

  • Symptom Relief: Research suggests that lozenges containing AMC/DCBA were associated with a greater reduction in patient-reported throat soreness and pain compared to placebo.
  • Onset of Action: Findings from some clinical studies indicate that the onset of symptomatic relief may be observed shortly after administration, with effects lasting up to two hours after a single dose.
  • Difficulty Swallowing: Clinical assessments frequently examine the effect on dysphagia (difficulty swallowing). Trials indicate an association between the active lozenges and a greater reduction in the difficulty of swallowing compared to unmedicated controls.

Additional Research Focus

Research Area Description of Findings
Antimicrobial Activity In laboratory (in vitro) studies, the AMC/DCBA combination demonstrated activity against certain bacteria and enveloped viruses associated with common mouth and throat infections.
Postoperative Use Some research has evaluated the use of the lozenges before general anesthesia to explore the potential for reducing the incidence and severity of postoperative sore throat (POST) and associated symptoms.

Key Studies & References

  1. European Medicines Agency (EMA) - Quality Review of documents for 2,4-Dichlorobenzyl alcohol and Amylmetacresol as medicinal products.

Frequently Asked Questions (FAQ)

Common questions about Strepsils Max (FAQ)


Q: How quickly can I expect Strepsils Max to start helping a sore throat?

Studies and official information indicate that the active substance is designed for rapid local action. Research suggests that the lozenge may exhibit signs of local anesthetic action within 1 to 5 minutes after placing it in the mouth.


Q: Is it possible for Strepsils Max to cause an allergic reaction?

Yes, official documents list the potential for hypersensitivity reactions (allergic reactions) under Immune System Disorders. The frequency of these reactions is officially classified as 'Not known,' meaning it cannot be estimated from the available data.


Q: Are there any specific foods or drinks that should be avoided while using Strepsils Max?

Official regulatory documents state that no clinically significant interactions with food, alcohol, or other forms of interaction are known for this medicine.


Q: What kind of cough, if any, is Strepsils Max described as helping?

The approved indication for this medicine is limited to the temporary relief of sore throat and mouth irritation. Cough is not listed as an approved use in official documentation.


Q: Can this product be used alongside commonly available pain relievers like paracetamol?

Official documents state that no clinically significant interactions with other medicinal products are known due to the compound's localized action.


Q: Has Strepsils Max been studied for use in pregnant women?

Official guidance notes that there is a limited amount of data from the use of the active substance, hexylresorcinol, in pregnant women. For this reason, official sources advise that the use of this product during pregnancy should be approached with caution.


Q: Is it normal to feel a temporary tingling sensation after using Strepsils Max?

Safety reports sometimes describe a temporary mild irritation, such as a burning or stinging feeling, at the site of application. This sensation is often related to the topical action of the ingredient and is typically mild.


Q: How long is the effect of one Strepsils Max lozenge expected to last?

The regulatory dosing schedule authorizes repeating administration every three hours as needed. Clinical studies suggest that symptomatic relief from a single dose may last up to two hours.


Q: Is it true that Strepsils Max has a higher concentration of the active ingredient than standard lozenges?

The 'Max' designation is used in the brand positioning to historically suggest an enhanced level of active ingredient or symptomatic relief when compared to standard Strepsils formulations.


Q: Can Strepsils Max interact with herbal supplements?

Official regulatory documents state that no clinically significant interactions with herbal products are known. This assessment is based on the localized action of the active substance.


Q: What is meant by the term 'local anaesthetic' in the context of this drug?

In the context of this medicine, a local anaesthetic is a substance that causes localized suppression of sensory nerve conduction in the throat. This action provides temporary relief by numbing the pain in the area of application.


Q: Are there different classifications or types of sore throat that this drug is intended for?

The approved indication for the product is for the temporary relief of occasional mouth and throat symptoms, such as minor irritation and pain, without specifying a classification.


Q: Can Strepsils Max cause drowsiness or affect my ability to drive?

Official regulatory documents state that there are no anticipated effects on the ability to drive or use machines. This is related to the drug’s design for localized action and minimal systemic absorption.


Q: What information is available about potential interactions with alcohol?

Official regulatory documents state that no clinically significant interactions with alcohol are known. The localized nature of the medicine’s action greatly limits its potential for drug-alcohol interactions.


Q: Is Strepsils Max intended to treat the underlying cause of a sore throat?

The medicine is approved for the temporary relief of symptoms of a sore throat and mouth irritation. Its function is to provide symptomatic comfort rather than to address the underlying cause of the irritation or infection.


Q: Can the lozenges be broken in half for easier use?

No. Official instruction is that the lozenge must be dissolved slowly in the mouth and not chewed or swallowed whole for the active substance to be released locally.


Q: Do regulatory agencies classify Strepsils Max as a medicine or a supplement?

Regulatory agencies classify this product as an Over-The-Counter (OTC) medicine. It is officially defined by its pharmacological class as a local anaesthetic and topical antiseptic.


Q: Are there any documented interactions with dental procedures or local anesthetics used by dentists?

Official documents state that no clinically significant interactions with other medicinal products are known. This determination is made because the active substance has minimal systemic absorption, which is necessary to mediate drug-drug interactions.


Q: What do official sources say about using Strepsils Max for a long period of time?

Use is officially constrained to a short-term duration, with the course of administration generally limited to a maximum of three consecutive days.


Q: Can Strepsils Max be used if I have other throat or mouth conditions, besides a sore throat?

The approved indication is for the temporary relief of sore throat and mouth irritation. The official product information does not include other specific, non-related mouth conditions.


Q: Is the sensation of numbing described as immediate or gradual?

Clinical research indicates a rapid onset of the local anesthetic effect. The sensation of numbness and subsequent relief is typically reported starting around 5 minutes after administration.


Q: Is the medication gluten-free according to manufacturer or regulatory information?

The product is generally regarded as gluten-free. This is because the wheat starch that may be used in it contains only very low levels of gluten, which fall below the threshold for gluten-free classification.


Q: Does Strepsils Max contain any ingredients derived from animals?

The active ingredient, Hexylresorcinol, is a synthetic organic compound. Information regarding all excipients is required to confirm the full composition.


Q: Can I use Strepsils Max if I have high blood pressure?

Official regulatory documents do not list any warnings, contraindications, or specific precautions related to the use of Hexylresorcinol lozenges in individuals with high blood pressure.


Q: Is Strepsils Max approved for treating specific mouth pain beyond a sore throat?

The official indication is for the temporary relief of sore mouth and sore throat. Other specific types of mouth pain are not included in the official indication for this product.


Q: What official information addresses the potential for taste disturbance as a side effect?

Taste disturbance (dysgeusia) is not explicitly listed as one of the commonly or rarely reported adverse events in the official product characteristics documents.


Q: Is there a descriptive statement in official documents about the duration of a sore throat that this medicine is for?

The product is intended for the relief of occasional symptoms. Official regulatory guidance advises that a patient should consult a healthcare professional if symptoms worsen or do not improve within 3 days.


Q: What does official guidance say about using Strepsils Max if I have a peptic ulcer?

Official regulatory documents do not list any warnings, contraindications, or specific precautions related to the use of Hexylresorcinol lozenges in individuals with a peptic ulcer.


Q: Is the active ingredient known to accumulate in the body over time?

Regulatory documents note that the product is designed for localized action with minimal systemic absorption, indicating it is not expected to accumulate in the body.


Q: Can I use this product if I have a known sensitivity to aspirin or other NSAIDs?

Official contraindications are specifically limited to known hypersensitivity to the active ingredient (hexylresorcinol) or its excipients (inactive ingredients).

How should Strepsils Max be stored and disposed of?

How to Store and Dispose of Strepsils Max?

The storage and disposal of Strepsils Max lozenges are defined by official regulatory requirements to ensure product stability and environmental safety.


Storage Conditions

Requirement Constraint
Temperature Do not store above 25 C
Protection Keep container tightly closed to protect from moisture
Child Safety Keep out of the sight and reach of children
In-Use Stability Use within 3 months of opening (for tube packaging)

The maximum storage temperature is 25 C. In addition to temperature control, the product must be protected from moisture by keeping the container tightly closed. The regulatory labeling strictly mandates that the product be kept out of the sight and reach of children.


Disposal Instructions

Official disposal instructions prohibit discarding unused or expired product via wastewater or household waste. Disposal must be completed according to local requirements for unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Strepsils Max found in:

A-Z Index: